Cambria Investment Management, L.P.
Position in CRL — Charles River Laboratories International, Inc.
CIK 1529389
Manhattan Beach, CA
Position in CRL
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$256,499
New position
Shares Held
1,131
first reported quarter
Ownership
0.002%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#381
of 569 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 0%
Shared 0%
None 100%
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Cambria Investment Management, L.P. holds $5,671,279 across 8 Diagnostics & Research names. CRL ranks #6 (4.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
5,532 | $2,773,523 | |
| 2 | DHR |
Danaher Corp /De/
|
5,128 | $976,781 | |
| 3 | NTRA |
Natera, Inc.
|
2,131 | $578,459 | |
| 4 | WAT |
Waters Corp /De/
|
927 | $347,662 | |
| 5 | IQV |
Iqvia Holdings Inc.
|
1,477 | $285,385 | |
| 6 | CRL |
Charles River Laboratories International, Inc.
This page
|
1,131 | $256,499 | |
| 7 | IDXX |
Idexx Laboratories Inc /De
|
450 | $236,898 | |
| 8 | MEDP |
Medpace Holdings, Inc.
|
408 | $216,072 |
All Filings in CRL
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $256,499 | 1,131 | Shares | Other | 2026-08-14 | |
| No filing history on record for this holder in this stock. | ||||||